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Infection of equids with Trypanosoma brucei (T. brucei) ssp. is of socioeconomic importance
across sub-Saharan Africa as the disease often progresses to cause fatal meningoencepha-
litis. Loop-mediated isothermal amplification (LAMP) has been developed as a cost-effective
molecular diagnostic test and is potentially applicable for use in field-based laboratories.
Part I
Threshold levels for T. brucei ssp. detection by LAMP were determined using whole equine
blood specimens spiked with known concentrations of parasites. Results were compared to
OIE antemortem gold standard of T. brucei-PCR (TBR-PCR).
Results I
Threshold for detection of T. brucei ssp. on extracted DNA from whole blood was 1 parasite/
ml blood for LAMP and TBR-PCR, and there was excellent agreement (14/15) between
tests at high (1 x 103/ml) concentrations of parasites. Detection threshold was 100 para-
sites/ml using LAMP on whole blood (LWB). Threshold for LWB improved to 10 parasites/ml
with detergent included. Performance was excellent for LAMP at high (1 x 103/ml) concen-
trations of parasites (15/15, 100%) but was variable at lower concentrations. Agreement
between tests was weak to moderate, with the highest for TBR-PCR and LAMP on DNA
extracted from whole blood (Cohen’s kappa 0.95, 95% CI 0.64–1.00).
Part II
A prospective cross-sectional study of working equids meeting clinical criteria for trypanoso-
miasis was undertaken in The Gambia. LAMP was evaluated against subsequent TBR-PCR.
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Results II
Whole blood samples from 321 equids in The Gambia were processed under field condi-
tions. There was weak agreement between LWB and TBR-PCR (Cohen’s kappa 0.34, 95%
CI 0.19–0.49) but excellent agreement when testing CSF (100% agreement on 6 samples).
Conclusions
Findings support that LAMP is comparable to PCR when used on CSF samples in the field,
an important tool for clinical decision making. Results suggest repeatability is low in animals
with low parasitaemia. Negative samples should be interpreted in the context of clinical
presentation.
Introduction
Trypanosomiasis is a potentially fatal haemolymphatic disease causing acute profound anae-
mia or a chronic cachexic syndrome. The disease has a high prevalence in working equids
across sub-Saharan Africa, where the extracellular parasites are commonly tsetse fly transmit-
ted (Glossina spp.). Disease caused by parasites from the Trypanozoon subgenus (Trypanosoma
brucei ssp.) can result in infection of the central nervous system, causing neurological abnor-
malities including ataxia, somnolence and inevitably death. In The Gambia trypanosomiasis is
hyperendemic. It contributes to loss of productivity and a high reported mortality in equids,
sufficient to exceed live birth rate, with the potential to affect significantly the welfare of reliant
communities [1–3].
Disease phenotype varies depending on the species of parasite involved. Various T. brucei
ssp., including T.b. brucei, T.b. equiperdum and T.b. evansi, as well as T. vivax and T. congo-
lense have been identified in The Gambia [4,5]. The early stages of disease in equids are associ-
ated with non-specific signs of infection such as pyrexia, anaemia, diarrhoea and abortion.
Occasionally dependent or genital oedema or dermal plaques may be seen. Without treatment
animals can die acutely or disease can last from months to years, with weight loss leading to
cachexia, or in the case of T. brucei ssp. progression to neurological disease [6–9].
Disease surveillance is limited and has historically been based on visualisation of parasites
microscopically in blood smears, buffy coat examination or lymph node aspirate. Reported
sensitivity is low (between 100–10000 parasites/ml, technique dependent) [10,11] and specia-
tion based on morphology is unreliable [12]. T. brucei ssp. are indistinguishable by available
molecular tests and therefore this manuscript refers to T.b. evansi, T.b. equiperdum and T.b.
brucei collectively as ‘T.brucei ssp.’ from this point. Diagnosis of T. brucei ssp. is complicated
further by periods of low circulating parasitaemia when the parasite is sequestered in the tis-
sues [13,14], and is rarely achieved prior to onset of neurological signs. Consequently treat-
ment is often delayed since this is dependent on recognition of non-specific clinical
abnormalities.
In equids the current gold standard for ante-mortem diagnosis of trypanosomiasis is
reported as PCR [15], with TBR-PCR having the greatest demonstrable sensitivity for T. brucei
ssp. [16]. Molecular methods suggest that the prevalence of T. brucei ssp. in equids in The
Gambia ranges from 14%-20% [4,5,9]. Due to the possibility of low levels of parasitaemia in
infected individuals TBR-PCR on samples gathered in the field cannot be described as a defini-
tive antemortem test [17].
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Neurological disease has been confirmed by demonstration of parasites in the neuropil
using immunohistochemistry in animals with clinical signs [18]. The disease is invariably fatal
once parasites reach the central nervous system with available treatment reported to be ineffec-
tive [10].
Molecular techniques such as TBR-PCR are of limited use for field-based diagnosis in this
susceptible population due to expense and the requirement for specialised equipment. A highly
sensitive field-applicable molecular test would greatly improve quality and efficacy of disease
surveillance, leading to earlier diagnosis, improved welfare and more informed treatment
strategy.
Loop-mediated isothermal amplification (LAMP) for T. brucei ssp., originally developed by
Notomi et al. [19], is resistant to biological contamination and therefore can be used on a vari-
ety of biological templates [20]. LAMP has been demonstrated to have a high sensitivity and
specificity for T. brucei ssp. [20–23]. The technique relies on a Bst DNA polymerase with a
high strand displacement activity under isothermal conditions resulting in rapid DNA amplifi-
cation. Reagents can be dried, simplifying storage of kits in areas where electricity and cooling
facilities are limited [24]. The test requires limited sample processing and provides a visual
result, with no post-processing of the amplification product, rendering the test potentially
applicable to use in a field-based laboratory.
LAMP for T. brucei ssp. (RIME-LAMP) targets the repetitive mobile insertion element (500
copies per haploid genome [25]), enabling detection at low concentrations of parasite, and has
been evaluated in many studies [20,22,23,26–29]. LAMP has been suggested as part of a
screening procedure in clinical cases of sleeping sickness in humans [30].
The aim of the current study was to evaluate the practicality and efficacy of LAMP as a field
based diagnostic for equine trypanosomiasis. It was hypothesised that LAMP would be suitable
for field use in clinical cases of equine trypanosomiasis in a resource poor region. The diagnos-
tic performance of LAMP was hypothesised to be equivalent to TBR-PCR for the detection of
T. brucei ssp. in equine blood.
Materials and methods
Threshold study
A threshold in vitro validation study was employed to assess the analytical sensitivity of LAMP
(RIME-LAMP) in diagnosing infection with T. brucei ssp. using whole equine blood template
with known parasite concentrations. This was performed across a range of packed cell volumes
to determine the effect of PCV on readability of the LAMP and was compared to TBR-PCR
(Fig 1, Table 1).
Samples were created at five packed cell volumes (PCV) from 10% to 50% by serial dilution
(10x) each starting at 1 x 103 parasites/ml until 1 x 10−3 parasites/ml. Each sample was then
tested in triplicate to give a total of 21 samples at each PCV, and 15 at each parasite
concentration.
Serial dilution
Serial dilutions of T.b. brucei (strain 947 x 247 hybrid) were made using mouse blood contain-
ing 2 x 104 parasites/ml. Whole defibrinated horse blood (E&O laboratories, Bonnybridge,
Scotland) was prepared to provide packed cell volumes ranging from 10% to 50% at 10% incre-
ments by removing or adding a calculated amount of defibrinated serum. PCV values were
confirmed using microhaematocrit centrifugation (HaemataStat II™, EKF Diagnostics, Cardiff,
Wales) in duplicate.
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Blood representing each adjusted PCV (1900 μl) was combined with 100 μl trypanosome
infected mouse blood (containing 2 x 103 trypanosomes) and serial dilutions were performed
to make final concentrations between 1 x 103 and 1 x 10−3 parasites/ml (Fig 1). A negative con-
trol was created by adding 60 μl mouse blood to 1140 μl equine blood at each PCV to mirror
the constituents in the trypanosome spiked samples. Each sample was stored in EDTA, heparin
and on FTA cards (100 μl). Spiked samples were processed at reducing trypanosome
Fig 1. Sample table demonstrating design of in vitro experiment with whole blood containing serial dilutions of
trypanosomes at a range of packed cell volumes.
https://doi.org/10.1371/journal.pone.0237187.g001
Table 1. Molecular tests performed on each template.
Template LAMP TBR-PCR
Whole blood ✔ ✖
Whole blood with detergent ✔ ✖
DNA extracted from whole blood ✔ ✔
DNA extracted from FTA cards ✔ ✔
https://doi.org/10.1371/journal.pone.0237187.t001
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concentrations, and then tested in triplicate until the concentration at which all three samples
were negative. Samples beyond this point in the dilution were not analysed. The negative con-
trol samples matching each PCV were also processed in triplicate.
DNA extraction from whole blood
DNA was extracted from 200 μl of EDTA blood using the Genesig Magnetic Bead extraction
kit (Primerdesign Ltd., Camberley, UK) according to manufacturer’s suggested protocol [31].
Final elution volume for the DNA was 200 μl.
DNA extraction from FTA cards
DNA extraction from Whatman1 FTA cards (GE Healthcare Ltd., Buckinghamshire, UK)
was performed using QIAamp DNA MicroKit (Qiagen, Hilden, Germany) for gDNA extrac-
tion according to manufacturers’ instructions [32]. Extractions using 3 x 2mm punches per
extraction were repeated in triplicate from each card to increase sensitivity of result [33]. Final
elution volume was 30 μl.
Preparation of LAMP template
LAMP was performed employing samples prepared by four different methods for use in the
threshold study: (i) DNA extracted from whole blood; (ii) DNA extracted from FTA cards;
(iii) whole blood using the ‘boil and spin’ method described below; (iv) whole blood using the
‘boil and spin’ method with added detergent.
Where extracted DNA template was used methods are as described above.
Boil and spin method. When preparing whole blood template for LAMP analysis using
the ‘boil and spin’ method, 100 μl of heparinised blood was added to 900 μl PCR grade water
and heated at 90˚C for 10 minutes before centrifugation at 14000 rpm for 3 minutes. 200 μl of
the resulting supernatant were stored at<5˚C prior to further testing. LAMP was performed
within 7 days of extraction.
When detergent was used 5 μl of 10% sodium dodecyl sulfate (SDS) solution was added to
45 μl of blood template. This was added to 450 μl PCR grade water before processing as
described above.
LAMP assay
Kits for LAMP were donated by Foundation for Innovative New Diagnostics (FIND, Geneva,
Switzerland), produced for use in humans (Loopamp, Eiken Chemical Co. Ltd., Japan). The
standard operating procedures for detecting T. brucei ssp. [34] were followed, with a total reac-
tion volume of 25 μl, comprising 5 μl sample template (either extracted DNA or template from
the ‘boil and spin’ method) and 20 μl of PCR grade water. A negative control (25 μl of PCR
water) and positive control (25 μl of provided template) was included with each test run (<14
tubes). A water bath (FisherbrandTM Isotemp Waterbath, 2L, Fisher Scientific, Loughborough,
U.K; laboratory) or LAMP incubator (LF-160 incubator, Eiken Chemical co, Taito-ku, Tokyo,
Japan; field, Gambia) was used for incubation. The reaction was set for 40 min at 62˚C. After
completion, tubes were examined by an observer (LG) and then either inserted into the fluo-
rescence unit (field; incorporated within the LAMP incubator) or examined with a handheld
UV lamp (laboratory).
Specificity of LAMP has been demonstrated previously [20] and was not re-validated in this
study.
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T. brucei ssp. PCR
PCR primers (Table 2) targeting a highly conserved region of equine cytochrome B (mito-
chondrial DNA) were used on all samples to confirm the presence of amplifiable DNA [35].
PCR primers (Table 2) targeting a multicopy, species specific region (177bp satellite region of
the minichromosome) found in T. brucei ssp. were used (TBR1 and TBR2; [16]). Sequences
are provided in Table 2. Anticipated specificity of primers was confirmed using BLAST [36]
and these primers have been widely used for detection of T. brucei ssp.
PCR amplification was conducted in a total reaction volume of 25 μl containing 2.5 μl tem-
plate DNA, 1 x HP Buffer containing 1.5 mM MgCl2 (ThermoFisher Scientific, Massachusetts,
USA), 0.2 mM dNTPs (ThermoFisher Scientific, Massachusetts, USA), 0.5 μM forward primer,
0.5 μM reverse primer (Eurofins Scientific, Luxembourg) and 1.25 U Thermo-Start Taq DNA
polymerase (ThermoFisher Scientific, Massachusetts, USA). Positive and negative controls
were also included. Amplification was initiated by a single cycle of 15 min at 92˚C. For equine
cytochrome B primers this was followed by 35 cycles of denaturation for 15 s at 94˚C, anneal-
ing for 30 s at 60˚C and extensions for 90 s at 72˚C. For T. brucei primers (TBR1 and TBR2)
PCR assays were as above with the only alteration being a lower annealing temperature of
55˚C. In all cases a final extension was included for 10 mins at 72˚C.
All PCR from extraction of whole blood included Thermo-Start Taq DNA polymerase
(ThermoFisher Scientific, Massachusetts, USA). DNA extracted from FTA cards was run
using Qiagen HotStarTaq1 Plus DNA Polymerase (Qiagen, Hilden, Germany). Reaction
composition was the same and PCR protocols were changed based on manufacturer’s recom-
mendations to an initial denaturation time of 5 min at 94˚C. Amplification products were
visualised on a UV transilluminator following electrophoresis through a 2% agarose gel con-
taining 1 μg/μl ethidium bromide.
Field study
Acquisition of samples in The Gambia. Field work was completed at 3 time points
between November 2017 and December 2018 in locations across the Central River District in
The Gambia. Owners were invited to present equids for examination and treatment. A history
was obtained with the assistance of translators provided by Gambia Horse and Donkey Trust.
Verbal informed consent was obtained from the owner prior to inclusion of their animal in
the study.
On presentation each animal was examined by an experienced equine vet for signs consis-
tent with trypanosomiasis. Body condition was scored [37], age was estimated from dentition
and a jugular blood sample was taken for measurement of packed cell volume (PCV %) and
total plasma protein (TP g/l) in order to assess hydration, degree of anaemia and requirement
for treatment. Centrifugation of micro-haematocrit capillary tubes was used to measure PCV
(HaemataStat II™, EKF Diagnostics, Cardiff, Wales). TP was measured on a handheld refrac-
tometer (Optika1, Ponteranica, Italy) that had been calibrated using deionised water.
Table 2. Primers used in PCR.
Primers Sequence Size of product
TBR1 GAATATTAAACAATGCGCAG 177bp [16]
TBR2 CCATTTATTAGCTTTGTTGC
EqCyB Fw GACCTACCAGCCCCCTCAAACATT 439bp [35]
EqCyB Rv CTCAGATTCACTCGACGAGGGTAGTA
https://doi.org/10.1371/journal.pone.0237187.t002
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Excess blood was placed into EDTA and heparinised tubes as well as a Whatman FTA1
Classic card. Samples were discarded following measurement of PCV and TP if the animals
did not meet trypanosomiasis inclusion criteria (detailed below). Blood was stored at<5˚C
prior to analysis.
Animals were included in the study if at least two of the following inclusion criteria were
fulfilled: body condition score�1.5/5; PCV�25%; temperature horse>38.5˚C, temperature
donkey>37.8˚C; limb, genital or ventral oedema; a history of abortion at any time prior to the
study, or neurological disease. Additional animals were included if a single criterion provided
strong clinical suspicion of trypanosomiasis. Animals that were reported as having treatment
with trypanocidal medication within a 4-week period prior to presentation or those with any
debilitating condition likely to result in death or euthanasia during the study period were
excluded from the study. However, these animals received veterinary care as indicated by their
presenting signs. If euthanasia was indicated it was discussed and performed with the permis-
sion of the owner using methods locally available to preserve the welfare of the animal.
Included animals were identified with a microchip (standard placement) and were treated
with isometamidium via a slow i.v. jugular injection (Intromidium, Interchemie, Holland, 0.5
mg/kg of 0.5% solution). Drugs were sourced from a verified reputable supplier. CSF samples
were obtained aseptically from the lumbosacral region of animals presenting with characteris-
tic signs of neurological trypanosomiasis using standard technique to enable clinical staging
[38]. Included animals also received treatment for any concurrent condition, including admin-
istration of non-steroidal anti-inflammatories, anthelmintic, or antimicrobials as indicated.
Animals were examined at 2 weeks to record response and any side effects of treatment and
then were re-examined at 3, 9 or 12 months after initial sampling. If additional samples were
taken paired testing was performed and included in analysis.
Processing of field-acquired samples. In vivo assessment of T. brucei ssp. infection status
was performed by LAMP analyses at the field-base in The Gambia. TBR-PCR could not be per-
formed on site therefore results were subsequently compared to TBR-PCR completed in the
laboratory following DNA extraction in the field, or from FTA card specimens extracted in the
laboratory.
At the field site DNA extraction and preparation of LAMP template was carried out as
described above except the centrifugation step which was limited to 6000 rpm due to equip-
ment available in the field. CSF, processed using the ‘boil and spin’ method, was additionally
tested from field-acquired samples when available.
Whole blood and LAMP templates were stored at<5˚C prior to processing; extracted DNA
was transported to University of Glasgow, Scotland and stored at -20˚C prior to analysis.
Repeat LAMP assays were performed at the field site on field acquired processed whole
blood samples to determine whether additional test positive animals would be identified.
These were randomly distributed across the individuals sampled.
Ethics statement
Animal use (infected mouse blood) was authorized in the United Kingdom under the Animals
(Scientific Procedures) Act 1986 and approved by the University of Glasgow Ethical Review
Committee.
Ethical approval for the field study was provided by University of Glasgow School of Veteri-
nary Medicine Research Ethics Committee (Reference 39a/17), and the Gambian Ministry of
Agriculture. Procedures were performed by trained veterinarians or local veterinary techni-
cians and were of direct benefit to the animals (categorised under Veterinary Surgeons Act
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1966). This was the criterion used by the committee for ethical approval and so the field study
did not come under the Animals (Scientific Procedures) Act 1986.
Statistical analysis
Number of tests required for adequate power was estimated using a simple nomogram [39]
and reported sensitivity and specificity for LAMP from field based samples (93% sensitivity
and 96.4% specificity [28]), and was estimated at 350–600 tests.
Statistical analysis was performed using SPSS (v.25 IBM Corporation, Armonk, NY, USA).
For laboratory validation Cohen’s kappa analysis was used to assess agreement between results
obtained using PCR and LAMP assays on different templates; results are reported with 95%
confidence intervals. Kappa coefficients and levels of agreement follow stringent recommenda-
tions [40]. For samples obtained in the field descriptive statistics were calculated to describe
the populations. Median and inter-quartile range were reported for continuous variables (con-
firmed as non-parametric using Shapiro-Wilk tests). Cohen’s kappa analysis was used as above
to analyse agreement from the first result of each test only (disregarding technical test repli-
cates). All tests performed on samples obtained over 1 month apart in individual animals were
included in kappa analysis to increase power. Number of test positives is reported from the
first result of each test only as a proportion of total samples tested.
Sensitivity is reported for each test at varying parasite concentrations during the threshold
study, however due to the lack of a definitive ante mortem test for T. brucei ssp. infection in
equids, sensitivity, specificity, negative predictive value (NPV) and positive predictive value
(PPV) are not reported for field results.
Results
Threshold of detection for T. brucei ssp. by TBR-PCR and LAMP
The results obtained from the analyses performed on the four different sample categories: (i)
LAMP on DNA extracted from whole blood (LEX); (ii) LAMP on DNA extracted from FTA
cards (LFTA); (iii) LAMP on whole blood (LWB) and (iv) LAMP on whole blood treated with
SDS detergent (LSDS) were compared with TBR-PCR on DNA extracted from whole blood
(PCREX) and TBR-PCR on DNA extracted from FTA cards (PCRFTA). The relative thresh-
olds for detection are represented in Table 3 and are reported as the concentration of parasites
per millilitre in the primary blood sample prior to processing. The extrapolated concentrations
of parasite in test samples are indicated in supporting information (S3 Table). There were no
positive results from any test on negative control samples. At high parasite concentrations
Table 3. Laboratory threshold study: Number of positive results for each diagnostic test at a range of parasite concentrations.
Test Sample Primer set Number of positive tests (total = 15)
Trypanosomes/ml
1000 100 10 1 0.1 0.01 0.001 -ve
LAMP Whole blood RIME 15 2 0 0 n.p. n.p. n.p. 0
Whole blood SDS RIME 15 15 3 0 n.p. n.p. n.p. n.p.
Extracted whole blood RIME 15 14 5 1 0 n.p. n.p. 0
Extracted FTA card RIME 11 1 0 0 0 n.p. n.p. n.p.
PCR Extracted whole blood TBR 14 8 5 1 0 n.p. n.p. 0
Extracted FTA card TBR 12 2 0 0 0 n.p. n.p. n.p.
Three test replicates combining data at each PCV ranging from 10–50%, total = 15, n.p.; not performed.
https://doi.org/10.1371/journal.pone.0237187.t003
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(1000 parasites/ml) all tests performed well, with LWB, LSDS and LEX detecting all positive
samples (including all packed cell volumes, 5 samples at each concentration were processed in
triplicate to give a total of 15/15 positive samples); PCREX detected 14/15, and this was
reflected in a high sensitivity for all tests (Fig 2), and a good agreement between tests. LEX and
PCREX had the highest analytical sensitivity, both detecting positives down to 1 parasite/ml.
PCRFTA and LFTA had the lowest analytical sensitivity alongside LWB (100 parasites/ml). At
lower concentrations parasite detection rate decreased, resulting in a lower sensitivity for all
tests (Fig 2), and no test method identified trypanosome DNA at or below 0.1 parasites/ml. At
100 parasites/ml LEX detected more positive samples (14/15) when compared to PCREX (8/
15), and LSDS detected more positive samples (15/15) than LWB (2/15).
Effect of PCV on test result. During laboratory validation a visual result was achieved at
all PCVs and was most easily identified using UV light (Fig 3). When all concentrations of try-
panosome were considered at each PCV, results were subjectively more variable for LAMP
across all categories (Fig 4). Higher numbers of positive results were seen across the tests at
10% and 50%, however PCV did not consistently influence test outcome.
Test repeats on LAMP assays
The cumulative positive result for each sample with a parasite concentration of over 10 para-
sites/ml was assessed over the three rounds of analysis (n = 15 to give a total of 45 tests). LEX,
LWB, LFTA and PCRFTA detected 2, 1, 1, and 3 additional positives samples respectively on
the second test round of analysis, but no further positive samples on the third test run (Fig 5).
This resulted in an overall false negative rate of 9/15 for LWB and LFTA and for PCRFTA and
LEX of 8/15 and 2/15 respectively. PCREX did not detect any additional positive samples on
the second round of analysis however 2 more positive results were seen on the third test run
resulting in a false negative rate of 1/15. LSDS was the only test with no additional positive
samples detected in subsequent rounds of analysis, with a resultant false negative rate of 4/15.
Cohen’s Kappa analysis
Cohen’s Kappa analysis (Table 4) across the range of serial dilutions showed almost perfect
agreement between PCREX vs LEX (0.95, CI 0.64–1.00), but agreement was lower for PCREX
Fig 2. Threshold study: Test sensitivity at varying parasite concentrations in blood. The ability of various tests to
detect trypanosomes at concentrations varying from 1000 trypanosomes/ml to 1 trypanosome/ml was assessed. The
results are depicted in the form of a heat map with detection ranging from 100% to 0% across the various samples and
tests. LWB: LAMP on whole blood template; LSDS: LAMP on whole blood treated with SDS detergent; LEX: LAMP on
DNA extracted from whole blood; LFTA: LAMP on DNA extracted from FTA cards; PCREX: TBR-PCR on DNA
extracted from whole blood; PCRFTA: TBR-PCR on DNA extracted from FTA cards.
https://doi.org/10.1371/journal.pone.0237187.g002
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vs LWB and PCREX vs LSDS. There was weak or minimal agreement between FTA card
extracted DNA and whole blood extracted DNA using identical techniques (PCREX vs
PCRFTA and LEX vs LFTA). LWB vs LEX and LWB vs LSDS had weak agreement whereas
for LWB vs LFTA and LSDS vs LEX, agreement was moderate.
Field capability of LAMP
Animals were examined from 13 villages across the central river district of The Gambia.
Descriptive data are summarised in supplementary data (S1 Table). A total of 510 horses and
donkeys were examined, and 315 animals fulfilled clinical inclusion criteria for trypanosomia-
sis: 114 horses (36.2%) and 201 donkeys (63.8%). 48.3% (n = 152) animals were female, 51.1%
(n = 161) were entire male and 0.6% (n = 2) were gelded males. Median age was 5 years (range
3 months to 25 years), with a median body condition score of 2/5 (range 0.5-3/5) [37]. Median
PCV was 25% (IQR 22–28%). Follow up data were included in order to increase power. Data
were included from 41 animals at a follow up of either 3 months (29) and 12 months (20) or 9
months (12) to give a total of 376 paired tests. Four animals were subsequently excluded due to
missing data to give a total sample size of 372 tests (Fig 6). For 183/372 samples, DNA was
extracted from the corresponding FTA cards for analysis due to concern about low level con-
tamination at the time of whole blood extraction. Following processing LAMP template
Fig 3. LAMP test result at range of PCVs at a concentration of 1000 parasites/ml in processed blood template. From left to right; negative
control, 10% (+), 20%(+), 30% (+), 40% (+), 50% (+), positive control. Fluorescent result is visible in all test tubes. A small amount of cellular
debris is visible at the bottom of the 50% tube (upper panel). This is confirmed by imaging in a UV transilluminator, where the positive results
show fluorescence (lower panel).
https://doi.org/10.1371/journal.pone.0237187.g003
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Fig 4. Threshold study: Number of test positives at a range of packed cell volumes at between 10 and 1000 parasites/ml in processed blood template. The number
of positive results across the range of packed cell volumes (PCV; 10% to 50% at increments of 10%) is depicted by the height of the bars. Colour of the stacked bar
represents type of test. Variability at the different packed cell volumes is present but generally inconsistent, with higher numbers of positive results at 10% and 50%.
LWB: LAMP on whole blood template; LSDS: LAMP on whole blood treated with SDS detergent; LEX: LAMP on DNA extracted from whole blood; LFTA: LAMP on
DNA extracted from FTA cards; PCREX: TBR-PCR on DNA extracted from whole blood; PCRFTA: TBR-PCR on DNA extracted from FTA cards.
https://doi.org/10.1371/journal.pone.0237187.g004
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(whole blood) for field analysis had subjectively more haemoglobin content due to lower cen-
trifugation speeds.
Analysis of field-acquired samples. Prevalence using each individual test was similar to
or lower than those previously reported (Table 5). LWB and PCREX resulted in similar
Fig 5. Threshold study: Chart showing cumulative positive test results over 3 rounds of analysis at concentrations above 10 parasites/ml
(15 tests repeated in triplicate; n = 45). The number of test positive samples increases (between 1 and 3 additional positive samples) for all
tests other than LSDS over 3 test replicates. Tests on DNA extracted from whole blood (PCREX and LEX) and LAMP on detergent treated
blood (LSDS) appear to detect higher numbers of positive samples overall compared to those on DNA extracted from FTA cards (LFTA and
PCRFTA) or LAMP on a whole blood template (LWB). LWB: LAMP on whole blood template; LSDS: LAMP on whole blood treated with SDS
detergent; LEX: LAMP on DNA extracted from whole blood; LFTA: LAMP on DNA extracted from FTA cards; PCREX: TBR-PCR on DNA
extracted from whole blood; PCRFTA: TBR-PCR on DNA extracted from FTA cards.
https://doi.org/10.1371/journal.pone.0237187.g005
Table 4. Laboratory threshold study: Cohen’s Kappa result for each paired test and interpretation.
Test 1 vs Test 2 Kappa value (95% CI) Level of agreement
PCREX vs LWB 0.45 (0.20–0.70) Weak
PCREX vs LSDS 0.53 (0.16–0.90) Weak
PCREX vs LEX 0.95 (0.64–1.00) Almost perfect
PCREX vs PCRFTA 0.41 (0.10–0.72) Weak
LWB vs LEX 0.53 (0.26–0.80) Weak
LWB vs LSDS 0.57 (0.22–0.92) Weak
LWB vs LFTA 0.78 (0.39–1.00) Moderate
LEX vs LSDS 0.61 (0.24–0.98) Moderate
LEX vs LFTA 0.34 (0.03–0.65) Minimal
Levels of agreement; <0.20: None; 0.21–0.39: Minimal; 0.40–0.59: Weak; 0.60–0.79: Moderate; 0.80–0.90: Strong;
>0.90: Almost perfect [40].
LWB: LAMP on whole blood template; LSDS: LAMP on whole blood treated with SDS detergent; LEX: LAMP on
DNA extracted from whole blood; LFTA: LAMP on DNA extracted from FTA cards; PCREX: TBR-PCR on DNA
extracted from whole blood; PCRFTA: TBR-PCR on DNA extracted from FTA cards.
https://doi.org/10.1371/journal.pone.0237187.t004
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numbers of positive tests (9.1% and 9.7% respectively), however there was a higher number of
test positive animals when results were combined (17.7%) due to incomplete overlap. Combi-
nations of positive results are detailed in supplementary data (S2 Table).
Six CSF samples were initially obtained from 5 animals and showed 100% agreement (5/5
of initial samples positive on LAMP using whole CSF template and TBR-PCR on extracted
DNA). One animal was resampled 3 months after treatment and was negative on both tests.
Cohen’s Kappa analysis on field-acquired samples. Cohen’s Kappa was used to compare
test agreement (Table 6). Agreement was minimal between LWB vs LEX/LFTA (0.39, 95% CI
0.17–0.49) or LWB vs PCREX/PCRFTA (0.34, 95% CI 0.19–0.49). When analysing data from
FTA cards in isolation, agreement between PCRFTA vs LWB (n = 179) was 0.23 (95% CI
0.03–0.43). When comparing PCREX vs LWB (n = 193) Cohen’s kappa was 0.46 (95% CI
0.25–0.69).
Fig 6. Field study: Diagram of samples analysed. Total number of included field-acquired samples was 372 after exclusions. LAMP analysis on
whole blood (LWB), DNA extraction from whole blood and FTA card application were performed in the field. LEX, LFTA, PCREX and
PCRFTA were performed in the laboratory. Comparisons between results (Cohen’s kappa) were performed between LWB and laboratory tests,
and also between LAMP and PCR results from the same DNA samples. LWB: LAMP on whole blood template; LSDS: LAMP on whole blood
treated with SDS detergent; LEX: LAMP on DNA extracted from whole blood; LFTA: LAMP on DNA extracted from FTA cards; PCREX:
TBR-PCR on DNA extracted from whole blood; PCRFTA: TBR-PCR on DNA extracted from FTA cards.
https://doi.org/10.1371/journal.pone.0237187.g006
Table 5. Field study: Total number of positive T. brucei ssp. test results (n = 372).
Test positives All samples (% of test results positive)
Any test positive 65/372 (17.5%)
LAMP WB (LWB) 34/372 (9.1%)
LAMP extracted DNA (LEX/LFTA) 33/372 (8.9%)
PCR extracted DNA (PCREX/PCRFTA) 36/372 (9.7%)
Results from DNA extracted from whole blood (first result, excluding test replicates) and those from substituted
DNA extracted from FTA cards were combined to give total positive results for the tested population.
LWB: LAMP on whole blood template; LEX: LAMP on DNA extracted from whole blood; LFTA: LAMP on DNA
extracted from FTA cards; PCREX: TBR-PCR on DNA extracted from whole blood; PCRFTA: TBR-PCR on DNA
extracted from FTA cards.
https://doi.org/10.1371/journal.pone.0237187.t005
PLOS ONE Comparison of LAMP and PCR for field diagnosis of Trypanosoma brucei ssp. in equids
PLOS ONE | https://doi.org/10.1371/journal.pone.0237187 August 24, 2020 13 / 21
Test repeats of LAMP assays on field-acquired samples. Due to expected low parasitae-
mia, one or more test repeats were performed on 154/376 LWB assays on whole blood in the
field to assess expected increase in detection of positive animals (Fig 7). Repeat tests were per-
formed on the same template and were randomly distributed across the individual samples.
128 assays were repeated twice, 11 three times, 13 four times and 2 five times. 35 animals had a
positive result on first LAMP assay. Prevalence increased up to a total positive result of 45 ani-
mals (45/315, equating to a prevalence of 14.3%). Number of additional positive individuals
was observed to plateau with repeat tests.
Discussion
This is the first study evaluating field-use of LAMP for the diagnosis of T. brucei infection in
equids. The laboratory threshold study describes the analytical detection limit of LAMP using
Table 6. Field study: Cohen’s Kappa result for each paired test detecting T. brucei ssp. in working equids and
interpretation (n = 372).
Test 1 vs Test 2 Kappa value (95% CI) Level of agreement
LWB vs PCRFTA/PCREX 0.34 (0.19–0.49) Minimal
LWB vs LFTA/LEX 0.39 (0.17–0.49) Minimal
PCRFTA/PCREX vs LFTA/LEX 0.57 (0.42–0.72) Weak
Levels of agreement; <0.20: None; 0.21–0.39: Minimal; 0.40–0.59: Weak; 0.60–0.79: Moderate; 0.80–0.90: Strong;
>0.90: Almost perfect [40].
LWB: LAMP on whole blood template; LEX: LAMP on DNA extracted from whole blood: LFTA: LAMP on DNA
extracted from FTA cards; PCREX: TBR-PCR on DNA extracted from whole blood; PCRFTA: TBR-PCR on DNA
extracted from FTA cards.
https://doi.org/10.1371/journal.pone.0237187.t006
Fig 7. Field study: Chart to show cumulative positive results compared to number of repeat LAMP assays on a single sample. The
number of individuals with a positive test results (red) is plotted against the total number of test replicates performed (blue, LAMP test on
whole blood; LWB). The number of positive individuals increases up to 4 test replicates but starts to plateau between 2 and 4 test replicates.
https://doi.org/10.1371/journal.pone.0237187.g007
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DNA extracted from whole equine blood by field-applicable methods. This was higher than
previously reported for RIME-LAMP which has been described at 100 trypanosomes/ml with
4 primers [20] compared to 1 trypanosome/ml in this study (Table 3). DNA contained in 1
parasite is estimated at 0.1pg [41]. Therefore, although higher sensitivities of TBR-PCR have
been reported previously (down to 0.1 trypanosomes/ml) [16] using these field-applicable
methods the detection limit of LAMP equalled that of TBR-PCR. Quantification of DNA fol-
lowing sample processing was not possible as part of this study.
Performance of LAMP on DNA extracted from whole blood exceeded TBR-PCR at 100 par-
asites/ml with fewer false negative results, indicating LAMP is likely to detect animals with the
same level of parasitaemia. Previous studies suggest the sensitivity of LAMP to be equal to or
greater than PCR [22,42,43], although in this study the greater test volume (5μl compared to
2.5μl for TBR-PCR) is likely to have contributed to this result. The addition of 2 further prim-
ers has been reported to increase the sensitivity of LAMP further, with a positive result at only
0.001 trypanosomes/ml [20]. Test sensitivity decreased for both tests at or below 10 parasites/
ml and when testing DNA extracted from FTA cards, despite processing FTA card samples in
triplicate. Parasite DNA on FTA cards is likely to be fixed and unevenly distributed across the
card, leading to a stochastic sampling effect and possible underestimation of prevalence [33].
Positive test results were observed using LAMP on a whole blood template (LWB) with a
detection limit of 100 parasites/ml which was improved to 10 parasites/ml by the addition of
SDS (LSDS) in the laboratory threshold study. Inclusion of detergents causing cell lysis has
been described in whole blood template, CSF and prior to application of blood to FTA cards
and improves sensitivity of LAMP [26,44]. This step was not included in the field study here
due to the increased risk of sample contamination. However, LAMP on SDS treated samples
has been used for T.b. gambiense detection in human CSF with promising results [44], and
could be evaluated in field-based studies in equids in the future.
Detection of positive samples in the threshold study increased with test repeats, and this
was most evident at low concentrations of parasites. In all samples treated with SDS the first
LAMP test result was predictive of replicate results, potentially suggesting cell lysis reduces
variability in test results due to a lower likelihood of sampling error [26]. Previous studies have
used three test replicates to formulate a basis for results [26], and results in this study demon-
strated 100% sensitivity following 3 repeats for both PCR and LAMP in samples containing
above 100 parasites/ml when using DNA extracted from whole blood. Sensitivity of LAMP on
whole blood template was also 100% at 1000 parasites/ml, but fell to only 20% at 100 parasites/
ml, which was the limit of detection for this template. This could be associated with a lower
total amount of parasite DNA within the sample, inhibition of the reaction by haemoglobin or
a reduced ability to detect a positive result in templates prepared from whole blood as reported
in previous studies [24,45], although the effect of PCV was not replicated in the comparison
between blood samples with varying packed cell volumes (Fig 4).
Paired LAMP tests using different templates but with similar paired analytical sensitivities
(LEX vs LSDS and LWB vs LFTA) had higher levels of agreement according to Cohen’s kappa.
Low parasite concentration (which increases the chance of sampling error) and low prevalence
conversely can affect Cohen’s Kappa negatively [26,44,46]. This should be considered when
interpreting Cohen’s Kappa result for paired samples.
No negative controls displayed positive results during the threshold study. Specificity of
primer binding in both RIME-LAMP and TBR-PCR is high as demonstrated previously
[20,42]. Overall, sensitivity and specificity of TBR-PCR is reported generally as high (summary
values of 99.0% and 97.7%), although specificity was variable (55.6%-82.9%) across multiple
studies using PCR on satellite targets [17]. The low values reported for specificity in those stud-
ies is likely to have resulted from adoption of microscopic identification of parasites as the
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reference standard. In a study using pooled spiked tsetse fly midguts, specificity of RIME--
LAMP was higher than TBR-PCR (75% and 26% respectively), but false positive LAMP results
have also been reported occasionally [22].
When used under field laboratory conditions, LAMP was successful in detecting T. brucei
ssp. infection in working equids and was particularly sensitive in confirmation of CNS try-
panosomiasis in animals presenting with neurological signs. Test result interpretation of
LAMP on whole blood template was subjectively more challenging in field conditions due to
lower centrifugation speeds resulting in more haemoglobin transfer into the template, compli-
cating direct comparison with the supplied positive control. This may have decreased sensitiv-
ity for recognition of a positive result [45]. Studies have described different methods for
improving detection of test result such as the addition of hydroxynaphthol blue [47], and this
approach could be trialled in future studies.
When results from both tests on field-acquired samples were combined, a higher number
of individuals were classified as positive (17.5%) than for either individual test. One explana-
tion for this is that each test is selecting different positive cases based on alternative target
sequences for amplification; TBR-PCR targets a satellite sequence with 1000 copies [48] while
RIME-LAMP targets 500 copies/haploid genome [25]. Alternatively, either test may be gener-
ating false positive or negative results.
Reduced prevalence of disease in field acquired samples was observed using TBR-PCR test
results alone compared to previous studies in this population [4,9]. One study used whole
genome amplification prior to PCR [4], the other used larger volume whole blood extraction
[9] possibly increasing sensitivity. If prevalence is underestimated in this study it may be
explained by methods, template type or preparation resulting in different DNA yields or the
presence of inhibitors. Processes were limited by those applicable to field conditions, minimis-
ing cost, waste and contamination risk. Animals with clinical signs indicative of trypanosome
infection, that returned a negative result on analysis, may have been infected with other species
of trypanosome (T. vivax or T. congolense), and mixed infections have been reported [4,9]
however testing for all species was beyond the scope of this study.
Test agreement between TBR-PCR and LAMP was excellent on CSF samples (6/6), poten-
tially due to large quantities of parasite DNA in the CSF of neurological individuals, or reduc-
tion in inhibitors resulting in improved test sensitivity with this template. LAMP could
therefore be recommended for disease staging in the field in animals with neurological signs of
disease or positive for T. brucei ssp. on whole blood analysis. Accurate staging of this disease is
considered vital in humans [49] and could be important in equids as treatment with non-CNS
penetrant trypanocidal agents in CNS-stage infections have been shown to exacerbate the neu-
roinflammatory reaction associated with trypanosome infection in a murine model [50]. No
medications have yet been shown to be successful at treating the neurological stage of disease
in equids.
When testing field-acquired samples, agreement was weak for TBR-PCR and LAMP. The
substitution of DNA extracted from FTA cards rather than from blood for the PCR may have
resulted in a lower sensitivity and agreement (as demonstrated in the threshold study). Low
levels of parasitaemia could also have influenced test agreement. In a previous field-based
study test agreement between RIME-LAMP and 18S PCR on samples obtained in the field
from humans with positive parasitological diagnosis was good (Cohen’s Kappa 0.61, 95% CI
0.45–0.77), but in suspected cases (high CATT or trypanolysis positive with no parasitological
diagnosis, and presumably with lower level parasitaemia) was only minimal (Cohen’s Kappa
0.39, 95% CI 0.22–0.56) [28].
TBR-PCR is likely to result in false negative test results when parasitaemia in infected ani-
mals falls below the limits of detection [13]. Due to the lack of a definitive gold standard test
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for the diagnosis of T. brucei ssp. infection ante mortem, the specificity of LAMP could not be
confirmed in this study. Definitive diagnosis may be achieved by post-mortem and immuno-
histochemistry [18], but was not possible in this population.
In this field study, as in the threshold study, up to 3 test repetitions resulted in the identifi-
cation of additional positive individuals. In screening the general population, the possibility of
a lower prevalence of disease and its effect on the interpretation of results should be considered
[51]. A sensitive test is beneficial, but increased test repeats could potentially increase the risk
of false positive results. The plateau reached in this study at higher numbers of repeat assays
suggest that additional positives are unlikely to be a function of the number of test repeats.
Future field studies could incorporate SDS to improve LAMP sensitivity over fewer test repeats
[44].
Conclusion
The findings of this study support the application of LAMP as a suitable screening test for use
in the field, providing a means of T. brucei ssp. diagnosis in resource poor regions. T. brucei
ssp. LAMP detection rates are comparable to TBR-PCR when used on samples with high para-
sitaemia, and on CSF samples under field conditions, offering an important additional tool for
clinical decision making. The use of detergents is recommended for future field trials to help
increase sensitivity and repeatability in LAMP, and negative samples should be interpreted
with caution in the context of clinical presentation.
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